TP53 and myelodysplastic syndrome: TP53 gene mutations were detected in 8–13% of MDS patients, were associated with complex karyotypes [36], and were mutually exclusive with RNA splicing factor gene mutations, mainly with the U2AF1 gene mutation [35].